Tunstall Americas acquires Providence Lifeline Medical Alert Service
LONG ISLAND CITY, NY – Tunstall Healthcare Group, through its U.S. subsidiary Tunstall Americas, has acquired Providence Lifeline Medical Alert Service. The acquisition continues the remote care and safety monitoring company’s expansion across the country. “This is our largest acquisition to date and helps us to fulfill our vision of helping people remain safe, healthy and independent at home through innovative health care technology and high-touch personal monitoring services across the country,” said Oscar Meyer, president and CEO of Tunstall Americas, in a statement.
mHealth market to reach $111B, report finds
SAN FRANCISCO – The global mHealth market is expected to reach $111.8 billion by 2025, growing at a compound annual growth rate of 44.2%, according to a new report by Grand View Research, Inc. The need to reduce long waiting periods to access health care facilities from specialists is the primary driver responsible for such growth, the report said. Other report findings include: patients are playing an important and active role in staying informed and updated on their own health care decisions, contributing to the rise in adoption of mHealth apps globally; and physicians are increasingly recommending the use of mHealth apps to their patients, which is likely to increase the adoption rate of mHealth apps.
Connected for Care rebrands, launches platform upgrade
LOMBARD, Ill. – Connected for Care has rebranded to the name Curatess, offering an integrated care coordination platform that enables advanced telemedicine delivery in post-acute settings. The brand and name change coincides with the launch of the company’s second-generation product platform, which includes a streamlined medical grade cart, easy-to-use software, EHR/EMR integration, Bluetooth integration of medical devices (stethoscope, pulse oximeter and blood pressure) and mobile applications. “The advantages of using a platform like ours is that it opens the opportunity to offer patient-centered care and not just 9 am – 5 pm care, but care when patients and nurses need support after-hours, or have distance challenges, or medically complex situations,” said Paul Knight, founder and chief information officer of Curatess.
Diener to lead headache disorder studies
CAMBRIDGE, Mass. – Dr. Hans-Christopher Diener has joined the clinical advisory board of Curelator Inc. to design and lead several multi-center global studies in headache disorders using the Curelator Headache mobile app. “We are delighted to have him join our team to design the first global real world clinical studies that employ a patient-centric digital platform to measure outcomes of different treatment strategies,” said Alec Mian, CEO and founder of Curelator, in a statement. Diener is currently a professor of neurology, chairman of the Department of Neurology and director of the Essen Headache Centre at the University of Duisburg-Essen in Germany.
The studies will use the Curelator Headache app to measure the individual impact of treatment interventions for each patient participating in the studies.
Diabetes apps may not be sufficient for disease management
GAINSVILLE, Fla. – Many mobile apps for diabetes management may not be a reliable complement to clinical care, according to a paper published last month in the Diabetes Care online journal by researchers at the University of Gainesville. “Mobile health applications have been found to lack evidence-based support when functionalities and information provided in apps are compared with clinical guidelines for specific disease management,” wrote the researchers. The researchers used the Mobile App Rating Scale to analyze and rank the top free apps for diabetes management. They also looked at the number of diabetes-specific management tasks that the apps included, such as physical activity, nutrition, blood glucose testing, medication and insulin dosage, health feedback, and education. Overall, the apps scored high on aesthetics and engagement but poorly on information and quality, wrote the researchers.
MedMinder, Cyft partner to assist chronic condition management
CAMBRIDGE, Mass. – Automated pill dispenser provider MedMinder is teaming with Cyft to improve care management for people with chronic/complex conditions. Cyft uses artificial intelligence to help care management teams focus on these populations by using all of their data to identify the members most likely to benefit from specific interventions, increasing the effectiveness of their outreach by more than 200%. As part of the new partnership, Cyft will integrate in-home medication adherence data into their nightly predictions, using more recent and relevant data to accurately prioritize members for care management outreach based on actionable risk. “More relevant and recent information leads to better insights and plans of action,” said Leonard D’Avolio, CEO and cofounder of Cyft, in a statement. “We need to think beyond the clinic for data sources.” MedMinder customers using Cyft will now have a single solution for combining MedMinder medication data with other rich sources, including care management notes, call center information, and claims data to get a more complete picture of actionable risk and associated urgency. MedMinder will also serve as Bluetooth hub for smart devices in the home, such as scales and thermometers. Cyft will combine these new sources of in-home data to help their clients deliver more efficient care management interventions. “MedMinder is collecting the data of real medication consumption at home and by feeding the data to Cyft we’re now putting the pieces together to proactively guide care managers based on all available data,” said Eran Shavelsky, CEO of MedMinder, in a statement.
AliveCor detects AFib more frequently than routine care, study shows
SAN FRANCISCO – AliveCor Kardia mobile electrocardiogram diagnosed nearly four times as many cases of atrial fibrillation than traditional screening, according to a recent study published in the American Heart Association’s Circulation Journal. Researchers studied 1,000 patients age 65 and older with increased risk of stroke and randomly assigned them to either the AliveCor Kardia device or routine care over 12 months. The results showed that 19 patients in the group using the AliveCor monitor were diagnosed with AFib versus five in the group receiving routine care. The researchers concluded that twice-weekly screening with a mobile ECG is significantly more likely to identify incident AFib than routine care over a 12-month period.
Aifloo raises $6M for senior wristband
STOCKHOLM – Aifloo has raised $6 million to continue development of its artificial intelligence-powered smart wristband for seniors. “With this investment and support, we’re looking forward to growing the team and developing our product further,” said Michael Collaros, CEO and co-founder of Aifloo, in a statement. The wristband uses sensors and AI to monitor user behavior and lets caregivers know of any potential problems. “Using cutting-edge AI, we’ve developed a system that learns and analyses human behaviours to increase people’s safety and help caregivers provide help where it’s needed the most,” said Collaros.
Call for nominations for 2017 Telehealth Honors
HOBOKEN, N.J. – Nominations for the 2017 Telehealth Honors program are being accepted to recognize individuals and programs that provide exceptional patient care in the home using modern telehealth technology. The program is sponsored by Health Recovery Solutions, a remote monitoring platform provider, and award recipients will be announced during the opening reception at the National Association of Home Care & Hospice Conference in October.
PreparedHealth names Brainch marketing officer
CHICAGO – PreparedHealth has named Iqbal Brainch as chief marketing officer. “Having Iqbal join the team marks a major milestone for our company,” said Ashish Shah, CEO and founder of PreparedHealth. “We are ready to formally accelerate our marketing efforts to expand our reach nationally.” Brainch was former vice president of marketing and product strategy for OptionsCity. “I am thrilled to join PreparedHealth and help further the mission of empowering patients, their families and providers to experience optimal care in the home,” said Brainch.
AlayaCare secures $2.4M
MONTREAL – AlayaCare has raised $2.4 million in funding, allowing the home health care software provider to sustain its three-year annual sales growth percentage of 125% and to invest more in its product and people. “To receive this level of trust and support is a testament to how far we’ve come in a short period of time,” said Adrian Schauer, CEO of AlayaCare, in a statement. “Home care agencies in Canada, the United States and as far away as Australia are realizing how the software we built can not only strengthen their core business, but improve the delivery of care itself, ultimately generating better patient outcomes.” AlayaCare delivers an all-in-one cloud-based software solution that includes remote patient monitoring, e-health, clinical documentation, a mobile app for caregivers to facilitate on-site support and back-office functionality.
Accelerator accepts applications from home health technology entrepreneurs
FAIRFAX, Va. – The Inova Personalized Health Accelerator is accepting business plan applications from early stage health care technology firms with a focus on personalized health.
The IPHA provides C-suite coaches, customized plans, early stage capital, connections to strategic partners and later stage capital and connections to customers for health care technology and services entrepreneurs.
“This bespoke approach to enhance med-tech entrepreneurs’ efforts to accelerate new companies through the early stages of product design, capital formation and commercialization will serve as the foundation for a stronger health care ecosystem in the mid-Atlantic region,” said Kelly Schlageter, an Inova spokeswoman, in a statement.
Companies that qualify for the IHPA are pre-series A and/or seed stage companies with working prototypes of their technology who are seeking venture investment for product development and commercialization. The types of companies being sought include medical devices, diagnostics, digital health, sensor technologies, A.I./machine learning, genomics & precision medicine and software/analytics.
IPHA has a year-round, rolling application process, and will focus on a maximum of six companies at any time to provide individual attention.
Kyocera, University of Tsukuba to develop AI system to detect melanoma
KYOTO, Japan – Kyocera Corporation’s subsidiary, Kyocera Communication Systems Co., Ltd., has begun joint research with the University of Tsukuba to develop an artificial intelligence system capable of detecting melanoma and other skin diseases by analyzing digital images of a patient’s skin.
The two are using a database of more than 20,000 clinical images accumulated over 20 years by the University of Tsukuba Hospital’s Department of Dermatology to develop an image-recognition system accurate enough to distinguish several types of skin malignancies, including melanoma.
The next phase of their project will aim for image-based diagnostic support of any skin disease.
In addition to helping dermatology specialists, AI-based image recognition could allow accurate diagnoses in rural and remote areas lacking a local clinician, using pictures from smartphones or digital cameras to greatly improve healthcare outcomes, said the researchers in a statement.
Additionally, KCCS will bring unique AI-based image-processing expertise accumulated through Labellio, a cloud-based web service that allows any user to create a simple “drag-and-drop” image classifier powered by deep learning.
KCCS and the University of Tsukuba will conduct joint research through March 2018, aiming toward a commercial application in the fiscal year ending March 2020. They also plan to develop a system capable of identifying more than 2,000 different skin diseases from digital images by combining their respective resources and expertise in the future.